Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

6.1K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapidly progressive dementia with parkinsonism in the Italian CJD Registry: underlying pathology and clinical-biomarker clues for differential diagnosis.

Parkinsonism & related disorders·2026
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

The GPR17 agonist galinex restores oligodendrocyte maturation under inflammatory conditions.

Frontiers in pharmacology·2026
Same author

From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis.

Annals of neurology·2026
Same author

A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming.

Journal of translational medicine·2026
Same author

Association Between Freezing of Gait and Sleep Quality in People with Parkinson's Disease.

Brain sciences·2026

Related Experiment Video

Updated: May 4, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K

Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.

Tommaso Gosetti di Sturmeck1, Leonardo Malimpensa2, Gina Ferrazzano3

  • 1European Brain Research Institute (EBRI) Rita Levi-Montalcini, 00161 Rome, Italy.

International Journal of Molecular Sciences
|June 27, 2024
PubMed
Summary

Biomarkers in microRNA profiles can predict multiple sclerosis progression independent of relapse activity. This aids in personalizing treatment strategies for patients with relapsing-remitting multiple sclerosis.

Keywords:
miRNAmodeling approachmultiple sclerosisprogression independent of relapse activity (PIRA)

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.4K

Related Experiment Videos

Last Updated: May 4, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.4K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.4K

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Genomics

Background:

  • Multiple sclerosis (MS) pathophysiology involves inflammation and neurodegeneration.
  • Disease Modifying Therapies (DMTs) reduce relapses but not all disability progression.
  • Progression Independent of Relapse Activity (PIRA) significantly impacts long-term disability.

Purpose of the Study:

  • Identify microRNA (miRNA) biomarkers to predict PIRA in relapsing-remitting MS (RRMS).
  • Develop models for stratifying patients based on disease trajectory.
  • Enhance personalized treatment strategies for early MS stages.

Main Methods:

  • Analyzed miRNA profiles from peripheral blood mononuclear cells of 25 RRMS patients before and after high-efficacy DMTs.
  • Utilized Agilent microarrays for miRNA profiling.
  • Employed multivariate logistic and linear models with randomization tests for analysis.

Main Results:

  • Selected a subset of miRNAs correlated with PIRA and Expanded Disability Status Scale (EDSS) changes.
  • Developed a robust logistic model predicting PIRA status with high accuracy (AUC = 0.971).
  • Built a multilinear model using four miRNA predictors to describe EDSS changes.

Conclusions:

  • Multivariate modeling of miRNA expression shows promise for predicting MS disability progression.
  • Baseline miRNA profiles can stratify patients regarding PIRA risk.
  • These findings support the development of personalized therapeutic approaches for MS.